Our Pipeline
Celltaxis Pipeline
Strong Clinical Activity of our Immune Modulating Drug(s) in Multiple Indications
Pre-clinical
Phase I
Phase II
Phase III
Lymphedema
Lipedema
Lymphatic Targeting
Topical Delivery
Lymphedema
Lipedema
Lymphatic Targeting
Topical Delivery
We are beginning with lymphedema, but our approach to treating lymphatic disorders is universal and applicable to other inflammatory diseases including lipedema and dermatological indications.